TR200000461T2 - Bir transdermal terapötik sistemin suistimalinin önlenmesini sağlayan işlem. - Google Patents

Bir transdermal terapötik sistemin suistimalinin önlenmesini sağlayan işlem.

Info

Publication number
TR200000461T2
TR200000461T2 TR2000/00461T TR200000461T TR200000461T2 TR 200000461 T2 TR200000461 T2 TR 200000461T2 TR 2000/00461 T TR2000/00461 T TR 2000/00461T TR 200000461 T TR200000461 T TR 200000461T TR 200000461 T2 TR200000461 T2 TR 200000461T2
Authority
TR
Turkey
Prior art keywords
therapeutic system
transdermal therapeutic
prevent abuse
prevent
abuse
Prior art date
Application number
TR2000/00461T
Other languages
English (en)
Inventor
Becher Frank
Klink Ann-Katrin
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of TR200000461T2 publication Critical patent/TR200000461T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)

Abstract

Usulsüz bir oral uygulamanin önlenmesi için transdermal terapötik sisteme baskalastirici maddelerin eklenmesi amaçlanmistir.
TR2000/00461T 1997-10-01 1998-09-18 Bir transdermal terapötik sistemin suistimalinin önlenmesini sağlayan işlem. TR200000461T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19743484A DE19743484C1 (de) 1997-10-01 1997-10-01 Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems

Publications (1)

Publication Number Publication Date
TR200000461T2 true TR200000461T2 (tr) 2000-09-21

Family

ID=7844345

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00461T TR200000461T2 (tr) 1997-10-01 1998-09-18 Bir transdermal terapötik sistemin suistimalinin önlenmesini sağlayan işlem.

Country Status (23)

Country Link
EP (1) EP1019032B1 (tr)
JP (2) JP4755338B2 (tr)
KR (1) KR100552102B1 (tr)
AT (1) ATE228356T1 (tr)
AU (1) AU759609B2 (tr)
CA (1) CA2305432C (tr)
DE (2) DE19743484C1 (tr)
DK (1) DK1019032T3 (tr)
ES (1) ES2188021T3 (tr)
HK (1) HK1029919A1 (tr)
HU (1) HU226644B1 (tr)
ID (1) ID24333A (tr)
IL (1) IL134479A (tr)
MY (1) MY116425A (tr)
NO (2) NO319163B1 (tr)
NZ (1) NZ503643A (tr)
PL (1) PL193066B1 (tr)
PT (1) PT1019032E (tr)
SK (1) SK3332000A3 (tr)
TR (1) TR200000461T2 (tr)
TW (1) TW431894B (tr)
WO (1) WO1999016428A1 (tr)
ZA (1) ZA988904B (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19743484C1 (de) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
DE102004019916A1 (de) * 2004-04-21 2005-11-17 Grünenthal GmbH Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
JP7329857B2 (ja) 2018-10-17 2023-08-21 日榮新化株式会社 粘着シート及びその製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
DE4342174C1 (de) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
DE19743484C1 (de) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems

Also Published As

Publication number Publication date
NO20001691L (no) 2000-03-31
TW431894B (en) 2001-05-01
DE19743484C1 (de) 1999-01-28
AU9626598A (en) 1999-04-23
SK3332000A3 (en) 2000-11-07
CA2305432A1 (en) 1999-04-08
DK1019032T3 (da) 2003-03-10
JP2001517695A (ja) 2001-10-09
EP1019032A1 (de) 2000-07-19
NO20001492D0 (no) 2000-03-22
ATE228356T1 (de) 2002-12-15
WO1999016428A1 (de) 1999-04-08
AU759609B2 (en) 2003-04-17
MY116425A (en) 2004-01-31
ID24333A (id) 2000-07-13
HK1029919A1 (en) 2001-04-20
ES2188021T3 (es) 2003-06-16
NZ503643A (en) 2003-05-30
PL193066B1 (pl) 2007-01-31
NO319163B1 (no) 2005-06-27
CA2305432C (en) 2007-04-03
JP2009035561A (ja) 2009-02-19
EP1019032B1 (de) 2002-11-27
PT1019032E (pt) 2003-04-30
HUP0003476A2 (hu) 2001-02-28
DE59806468D1 (de) 2003-01-09
HU226644B1 (en) 2009-05-28
JP4755338B2 (ja) 2011-08-24
IL134479A (en) 2005-07-25
PL339736A1 (en) 2001-01-02
IL134479A0 (en) 2001-04-30
NO20001492L (no) 2000-03-22
HUP0003476A3 (en) 2001-04-28
NO20001691D0 (no) 2000-03-31
ZA988904B (en) 1999-04-12
KR20010030886A (ko) 2001-04-16
KR100552102B1 (ko) 2006-02-13

Similar Documents

Publication Publication Date Title
ATE386808T1 (de) Arzneimittelzubereitungen für die behandlung von alpha-galactosidase a-mangel
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
DE3787377T2 (de) Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.
AR032293A1 (es) Estuche farmaceutico
NO20011217D0 (no) Doseringsform omfattende væskeformulering
MA24794A1 (fr) D-methadone, un analgesique nonopioique
DK0800399T3 (da) Kombineret terapeutisk behandling af hyperproliferative sygdomme
TR200000461T2 (tr) Bir transdermal terapötik sistemin suistimalinin önlenmesini sağlayan işlem.
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
EA199800866A1 (ru) Способ снятия боли
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
NO20000814L (no) Identifikasjon for klebende flateformede dermale og transdermale terapeutiske administrasjonsformer under anvendelse av et klebende plaster som informasjonsbærer, såvel som fremgangsmåte for deres fremstilling
ZA962752B (en) Rate-controlled transdermal administration of risperidone.
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
PT862454E (pt) Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados
ATE229326T1 (de) Therapie von depressionen
FI901876A0 (fi) Ofullstaendiga hepadnavirus, vaccin producerande cellinjer samt terapi av leversjukdomar.
SE9504267D0 (sv) New therapeutic use
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
DE60028207D1 (de) Transdermales therapeutisches system zur verabreichung von calciumantagonisten
IT8720800A0 (it) Composto attivo nella terapia carciovascolare.
ZA977895B (en) Transdermal therapeutic system having an active compound combination comprising oestriol.
DE29501910U1 (de) Transdermales therapeutisches den Wirkstoff Dimethisoquin enthaltendes System
UA36385A (uk) Спосіб лікування генералізованого пародонтиту